• fuyu00@lemmy.blahaj.zone
    link
    fedilink
    English
    arrow-up
    4
    ·
    3 months ago

    No, it still wouldn’t address the insulin resistance, just the consequences of the β-cell dysfunction. Ideally therapy would address the hyperglycaemia and preserve β-cell functionality. Currently insulin is prescribed in T2D when two oral agents aren’t effective at controlling hyperglycaemia. So while potentially applicable, it would not be a solution.

    • davidgro@lemmy.world
      link
      fedilink
      English
      arrow-up
      1
      ·
      3 months ago

      Ah - when I posted the question I was thinking of my mom who was type 2 and needed to take insulin very regularly (and eventually had a continuous glucose monitor patch on her arm at all times)

      It does seem like it should help for cases like that, which I wasn’t aware were less common.